The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 26, 2022

Filed:

Jun. 19, 2018
Applicants:

The Broad Institute, Inc., Cambridge, MA (US);

Massachusetts Institute of Technology, Cambridge, MA (US);

President and Fellows of Harvard College, Cambridge, MA (US);

Inventors:

Feng Zhang, Cambridge, MA (US);

Le Cong, Cambridge, MA (US);

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/195 (2006.01); C07K 14/47 (2006.01); C12N 5/07 (2010.01); C12Q 1/6816 (2018.01); C12N 15/63 (2006.01); C07K 14/03 (2006.01); C12N 9/12 (2006.01); C12N 9/22 (2006.01); C12N 5/071 (2010.01);
U.S. Cl.
CPC ...
C12N 5/06 (2013.01); C07K 14/03 (2013.01); C07K 14/195 (2013.01); C07K 14/4703 (2013.01); C12N 5/0686 (2013.01); C12N 9/1241 (2013.01); C12N 9/22 (2013.01); C12N 15/635 (2013.01); C12Q 1/6816 (2013.01); C07K 2319/80 (2013.01);
Abstract

The invention relates to methods of altering expression of a genomic locus of interest or specifically targeting a genomic locus of interest in an animal cell, which may involve contacting the genomic locus with a non-naturally occurring or engineered composition that includes a deoxyribonucleic acid (DNA) binding polypeptide having a N-terminal capping region, a DNA binding domain comprising at least five or more Transcription activator-like effector (TALE) monomers and at least one or more half-monomers specifically ordered to target the genomic locus of interest, and a C-terminal capping region, wherein the polypeptide includes at least one or more effector domains, and wherein the polypeptide is encoded by and translated from a codon optimized nucleic acid molecule so that the polypeptide preferentially binds to the DNA of the genomic locus.


Find Patent Forward Citations

Loading…